LABNEW (LAB) fluctuates 20.7% in 24 hours: Whale accumulation and high trading volume drive rebound
Bitget Pulse2026/05/10 22:03Volatility Overview
In the past 24 hours, LABNEW (LAB) price rebounded from a low of $4.46 to a high of $5.3809, currently quoted around $4.76, with an amplitude of 20.7%. The 24-hour trading volume is approximately $55 million to $60 million, slightly down from the previous day but still active.
Analysis of Abnormal Movements
- Whale accumulation continues to push price rebound: On-chain monitoring shows whales have been actively buying in the past 24 hours, and combined with high trading volume, this has directly driven the rebound from the low of $4.32 to the high of $5.38.
- The overall increase exceeds 11%, and data from trading platforms show clear signs of net capital inflow, with an ATH of $5.19.
Market Views and Outlook
Market sentiment is divided. Community discussions focus mainly on manipulation risks and low circulating supply (with the team holding over 90%), warning retail investors to avoid the "liquidation hunt" trap. Although analysts such as ZachXBT have exposed team wallets, 98% of whale long positions remain profitable. Some traders are optimistic for a rebound to $6-$7, but emphasize that if support at $4.43 is lost, there could be a further 50% drop.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
NVIDIA (NVDA.US) management changes may affect Anthropic's IPO plans; the market is watching whether the multi-billion-dollar investment will change
With the sudden departure of Nvidia CEO Jensen Huang, the record-breaking initial public offering plan of AI giant Anthropic is being reconsidered by the market.
Nebius Q3 results exceed expectations, capital expenditure rises to $27 billion, ARR target postponed, stock falls over 14% pre-market | Earnings Report Insights
Nebius reported Q3 revenue of $981 million (a year-on-year increase of 571%) and adjusted EBITDA of $466 million, both exceeding expectations. However, the company delayed and lowered its guidance for annual recurring revenue (ARR), stating that it is no longer applicable. Additionally, it significantly raised its 2026 capital expenditure target to $27 billion, with projections to further increase to $40 billion to $45 billion in 2027. The stock price plummeted more than 14% in pre-market trading.
AUD/USD Price Forecast: Breakdown of H&S pattern keeps the pair under pressure
U.S. Stock Market Preview | Major Index Futures Mixed; Nvidia Plunges Pre-market; Fed Officials' Speeches Incoming
Before the U.S. stock market opens on Thursday, November 12, the three major U.S. stock index futures showed mixed movements.